Rowland Carmichael Advisors’s Elevance Health ELV Stock Holding History

Rowland Carmichael Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,677	Closed	-$643K	–	353
2019 Q3	$643K	Sell	2,677 -367	-12%	-$101K	0.22%	126
2019 Q2	$859K	Sell	3,044 -934	-23%	-$255K	0.3%	93
2019 Q1	$1.14M	Hold	3,978	–	–	0.42%	44
2018 Q4	$1.04M	Sell	3,978 -1,018	-20%	-$280K	0.46%	36
2018 Q3	$1.37M	Hold	4,996	–	–	0.53%	33
2018 Q2	$1.19M	Hold	4,996	–	–	0.5%	34
2018 Q1	$1.1M	Hold	4,996	–	–	0.6%	34
2017 Q4	$1.12M	Hold	4,996	–	–	0.58%	38
2017 Q3	$949K	Hold	4,996	–	–	0.53%	53
2017 Q2	$940K	Buy	+4,996	New	+$898K	0.54%	51

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Rowland Carmichael Advisors's ELV Position: Q4 2019 in Review

Rowland Carmichael Advisors sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 2,677 shares — an estimated $643K sold.

Rowland Carmichael Advisors first reported a position in ELV in Q2 2017 and held it in 10 quarters. The position peaked at $1.37M in Q3 2018. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

Rowland Carmichael Advisors reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
Rowland Carmichael Advisors sold 2,677 Elevance Health shares in Q4 2019, an estimated $643K.
Rowland Carmichael Advisors first reported a position in Elevance Health in Q2 2017 and held it in 10 quarters.
Rowland Carmichael Advisors's Elevance Health position peaked at $1.37M in Q3 2018.
1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.